Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Marc Gittelman"'
Autor:
Kalpesh Patel, Marc J. Pliskin, J. Randolf Beahrs, Lance A. Mynderse, Steven N. Gange, Jed Kaminetsky, David Prall, Kenneth Goldberg, Nicholas N. Tadros, Kevin T. McVary, Marc Gittelman, Claus G. Roehrborn, Richard Levin, Barrett E. Cowan, Christopher H. Cantrill, James Ulchaker, Neal D. Shore
Publikováno v:
Journal of Urology. 206:715-724
Purpose:We present final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor therapy (Rezūm™) for treatment of moderate to severe lower urinary tract symptoms due t...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1b767a7c3bf232d172c51ba72fcbc07
https://doi.org/10.1097/ju.0000000000001778
https://doi.org/10.1097/ju.0000000000001778
Autor:
Ronald Swerdloff, Christina Wang, Marc Gittelman, Jay Newmark, B Woun Seo, Nestor Rohowsky, Robert Dudley
Publikováno v:
Journal of the Endocrine Society. 6:A704-A705
In 2019, a novel, first-in-class testosterone (T) replacement therapy (TRT), oral testosterone undecanoate (TU) was approved by the U.S. FDA for the treatment of male hypogonadism. During clinical trials, dose adjustments were based on 24-hr average
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c1421f6be070e70a70b3de03821cae5
https://doi.org/10.1210/jendso/bvac150.1452
https://doi.org/10.1210/jendso/bvac150.1452
Autor:
Stanton Honig, Marc Gittelman, Jed Kaminetsky, Christina Wang, John K. Amory, Nestor Rohowsky, Robert E. Dudley, B. Woun Seo, Jay Newmark, Ronald Swerdloff
Publikováno v:
The journal of sexual medicine. 19(12)
Background Long-term data evaluating the efficacy and safety of oral testosterone undecanoate (oral TU; JATENZO) in adult hypogonadal men provides important information for healthcare professionals who prescribe testosterone replacement therapy (TRT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3f0bba14691a7d17c5b874262852e5
https://pubmed.ncbi.nlm.nih.gov/36272969
https://pubmed.ncbi.nlm.nih.gov/36272969
Autor:
Ronald Swerdloff, Jason Kovac, Christina Wang, Marc Gittelman, B. Woun Seo, Jay Newmark, Nestor Rohowsky, Robert Dudley
Publikováno v:
Journal of Urology. 207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12676df5f4147dbdf515f56ab3e773a8
https://doi.org/10.1097/ju.0000000000002589.09
https://doi.org/10.1097/ju.0000000000002589.09
Autor:
Jan M. Wruck, Marc Gittelman, Kristin Drda, Claus G. Roehrborn, Anne Esler, Anna E. Verbeek, Franklin C. Lowe
Publikováno v:
Urology Practice. 7:14-20
Introduction:We assessed the ability of men with bothersome urinary symptoms to use an over-the-counter tamsulosin (0.4 mg) product concordant with the information in the proposed drug fact...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8dbc88b87fa8aad1b9f6c1cd8f4e664
https://doi.org/10.1097/upj.0000000000000059
https://doi.org/10.1097/upj.0000000000000059
Autor:
Nestor Rohowsky, Ronald S. Swerdloff, Christina Yan Wang, Marc Gittelman, Parviz K. Kavoussi, B. Woun Seo, Robert E Dudley
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:An oral testosterone (T) replacement therapy (TRT) would be the preferred administration route for many hypogonadal men. Until recently, the only oral TRT approved in the...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbc74cba8be1bb9e1f4cbf791dd51c96
https://doi.org/10.1097/ju.0000000000002009.07
https://doi.org/10.1097/ju.0000000000002009.07
Publikováno v:
The Journal of Sexual Medicine. 16:1741-1748
Introduction Patients with testosterone deficiency (TD) can be treated with exogenous testosterone (T) to achieve and maintain physiologic T levels and prevent negative clinical symptoms; with many testosterone replacement therapies currently availab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999bbee607146168ed52ec81794e10a4
https://doi.org/10.1016/j.jsxm.2019.08.013
https://doi.org/10.1016/j.jsxm.2019.08.013
Autor:
W. Jennings, W. Ellison, Mark A. Reynolds, P. Church, C. White, M. Rhee, M. Noss, Nicolas Girard, D. Altamirano, J. Ervin, Stanley E. Althof, Katie George, Gary J. Muirhead, Ian H. Osterloh, G. Shockey, D.W. Schumacher, Abraham Morgentaler, Marc Gittelman, J. Kopp, Jack M. Miller, M. Efros, Michael A. Adams, Irwin Goldstein, F. Rauzi, C. Molin, M. Banov, Jed Kaminetsky, D. Francyk, E. Crocket, Martin Miner, H. Croft, C. Herman, S. Althof, Laurence Belkoff, S. Polepalle, R. Severance
Publikováno v:
The Journal of Sexual Medicine. 16:1188-1198
Introduction Cligosiban is an orally administered, centrally penetrant oxytocin receptor antagonist being developed to treat premature ejaculation (PE). Aim To determine the efficacy of 3 dose levels of cligosiban caplets to prolong intravaginal ejac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d363957fcaaae21887085342fe90a2f6
https://doi.org/10.1016/j.jsxm.2019.05.015
https://doi.org/10.1016/j.jsxm.2019.05.015
Publikováno v:
Translational Andrology and Urology. 8:329-338
Background: Tamsulosin remains the single most popular uroselective alpha adrenoceptor antagonist approved for the treatment of lower urinary tract symptoms (LUTS) attributable to benign prostatic hyperplasia (BPH). Over the last 3 decades, the utili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6608b6a5f4cefc765aed8d1288a0c439
https://doi.org/10.21037/tau.2019.07.02
https://doi.org/10.21037/tau.2019.07.02
Autor:
Ronald Swerdloff, Christina Wang, Marc Gittelman, B. Woun Seo, Jay Newmark, Nestor Rohowsky, Robert Dudley
Publikováno v:
Endocrine Practice. 28:S124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::420203db502f7641cd8e47cf5b2a3131
https://doi.org/10.1016/j.eprac.2022.03.291
https://doi.org/10.1016/j.eprac.2022.03.291